Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myelomaMatthew J. Rees, Shaji Kumar, Sikander Ailawadhi et al.|Blood Cancer Journal|2024Cited by 20
Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosisBinoy Yohannan, Eli Muchtar, Matthew J. Rees et al.|Blood Neoplasia|2025Cited by 18
Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survivalMatthew J. Rees, Eli Muchtar, Nadia Toumeh et al.|Amyloid|2025Cited by 8